Avalo Therapeutics Inc.

NASDAQ: AVTX
Share price (3/25/25): $8.54
Market cap (3/25/25): $91.1 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1 2024 – amended

ended 03/31/24 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement

Shelf registration – amended

Shelf registration – amended

Ownership Filter

Biotechnology Value Fund L P

Sullivan Christopher Ryan

Neil Garry Arthur

News Filter

Reports 2024 Financial Results and Recent Business Updates

Investor Presentation

Appoints Jennifer Riley as Chief Strategy Officer

Investor Presentation

Receives $69.4 Million in Proceeds From the Full Exercise of Private Placement Warrants

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC